Great Point Partners’s Zura Bio ZURA Stock Holding History

Great Point Partners’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9M	Hold	4,215,930	–	–	4.7%	6
2026 Q1	$25.1M	Buy	4,215,930 +400,000	+10%	+$2.42M	5.77%	3
2025 Q4	$20M	Hold	3,815,930	–	–	6.48%	3
2025 Q3	$16.5M	Buy	3,815,930 +645,736	+20%	+$1.16M	6.81%	4
2025 Q2	$3.33M	Hold	3,170,194	–	–	2.16%	19
2025 Q1	$4.09M	Hold	3,170,194	–	–	2.17%	22
2024 Q4	$7.93M	Sell	3,170,194 -93,478	-3%	-$333K	3.73%	12
2024 Q3	$13.3M	Sell	3,263,672 -1,378,569	-30%	-$5.15M	3.9%	10
2024 Q2	$16.2M	Buy	4,642,241 +1,884,501	+68%	+$7.68M	3.11%	12
2024 Q1	$7.09M	Sell	2,757,740 -537,260	-16%	-$1.9M	1.1%	31
2023 Q4	$15.4M	Hold	3,295,000	–	–	2.62%	18
2023 Q3	$21.7M	Hold	3,295,000	–	–	3.96%	8
2023 Q2	$27M	Buy	+3,295,000	New	+$26.5M	5.29%	7

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Great Point Partners's ZURA Position: Q2 2026 in Review

Great Point Partners held its Zura Bio (ZURA) position steady in Q2 2026 at 4,215,930 shares worth $24.9M. The position accounts for 4.7% of the portfolio, ranked #6.

Great Point Partners first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $27M in Q2 2023. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

Great Point Partners held 4,215,930 shares of Zura Bio worth $24.9M as of Q2 2026.
Great Point Partners left its Zura Bio share count unchanged in Q2 2026.
Zura Bio made up 4.7% of Great Point Partners's portfolio in Q2 2026, its #6 holding.
Great Point Partners first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
Great Point Partners's Zura Bio position peaked at $27M in Q2 2023.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Great Point Partners's 13F filing for Q2 2026, filed 14 Aug 2026.